Navigation Links
China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19

Teleconference to be Held at 8 a.m. EDT

SHENZHEN, China, March 10 /Xinhua-PRNewswire-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largest drugstore chain in China based on the number of directly operated stores, announced today that it will report financial results for the fourth quarter and fiscal year ended December 31, 2007, before the market opens on March 19, 2008.

The Company will host a conference call, to be simultaneously Webcast, on Wednesday, March 19, 2008 at 8:00 a.m. Eastern Daylight Time / 8:00 p.m. Beijing Time. A question-and-answer session will follow management's presentation. Interested parties may participate in the conference call by dialing the following numbers approximately five to ten minutes before the call start time:

+ 1-877- 407-9210 (North America)

+ 1-201-689-8049 (International)

A live Webcast of the conference call will be available on the Nepstar website at .

A replay of the call will be available starting on March 19, 2008, at 11:00 a.m. Eastern Daylight Time / 11:00 p.m. Beijing Time through March 26, 2008 at 11:59 p.m. Eastern Daylight Time or March 27, 2008 at 11:59 a.m. Beijing Time. An archived Webcast of the conference call will be available on the Nepstar Web site at . Interested parties may access the replay by dialing the following numbers and entering the account number and conference ID number below:

+1-877-660-6853 (North America)

+ 1-201-612-7415 (International)

Account Number: 286

Conference ID Number: 277575

About China Nepstar Chain Drugstore Ltd.

China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is China's largest retail drugstore chain based on the number of directly operated stores. As of December 31, 2007, the Company had 2,002 stores in 62 cities and 11 regional distributional centers in China. It uses directly operated stores, centralized procurement and a network of regional distribution centers to provide customers with high-quality, professional and convenient pharmacy services and a wide variety of other merchandise, including over-the-counter ("OTC") drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables and seasonal and promotional items. China Nepstar's strategy of competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the robust demographic and economic growth trends in China to achieve a strong brand and leading market position. For further information, please go to .

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its registration statement on Form F-1. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

For more information, please contact:

In China:

Lucia Qian

Marketing and IR Director

China Nepstar Chain Drugstore Ltd.

Tel: +86-755-2641-4065


In the United States:

Dixon Chen

Investor Relations

The Global Consulting Group

Tel: +1-646-284-9403


Ivette Almeida

Media Relations

The Global Consulting Group

Tel: +1-646-284-9455


SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
2. Smoking is major risk factor for stroke in China
3. China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies
4. China Sky One Medical, Inc. Appoints Four Independent Board Members
5. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
6. China Medical Technologies Reports Third Quarter Financial Results
7. China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd.
8. China Bionanometer Industries Corporation Announces New Products for China
9. China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results
10. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
11. China Holdings Announces Starwood Research Institute Initiates Research Coverage
Post Your Comments:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: